This LifeFunder campaign is no longer active.

Help JPII Institute develop ethical COVID vaccine

CAMPAIGN CLOSED BY STRIPE: 

Dear Friends,
As many of you may know, over the past two months John Paul II Medical Research Institute has been working with our friends at LifeFunder to promote our vaccine development efforts through a crowdfunding campaign on their website. 
This past week however, our Institute was informed by payment processor Stripe that our account with them would be getting shut down.
JP2MRI was informed by Stripe that we could appeal the initial decision and did do so for a more thorough explanation. 

We were then informed by the representative at Stripe that our account was being closed because they had reviewed our website and found that what we were advocating for and trying to develop was against their company policies.
We were shocked and disappointed to learn that the decision by Stripe was clearly politically motivated and based on the Institute’s scientific belief that the current vaccines on the market are not effective and needed a better, more ethical solution. Stripe has
informed JP2MRI today that their decision is final.
Consequently, since there is no way for donors to make donations to our campaign through LifeFunder, our campaign through
LifeFunder will end as of today.
Instead, we are asking all of our supporters to make their donations to our Campaign for Cures by visiting our website directly at:
Thank you very much for your continued support.
John Paul II Medical Research Institute
_________________________________________________________________________

2021 “Campaign for Cures” to Help Develop an Ethical COVID-19 Vaccine and Novel Therapies 

The John Paul II Medical Research Institute (JP2MRI) was established in 2006 with a mission to
find new therapies and cures exclusively using adult stem cells and induced pluripotent stem
cells. 
The Institute does NOT engage in any embryonic stem cell research and seeks to develop
preclinical research technologies that will advance drug discovery and regenerative medicine in
the following core research areas: 1) Neurodegenerative Diseases; 2) Rare Diseases; 3) Cancer;
and 4) Chronic Diseases. 
And, JP2MRI is also currently hoping to develop a more effective and ethical
SARS-CoV-2 vaccine that is free of all aborted fetal tissue and cell use in both development and
testing. 
The Institute is making progress on our vaccine developmental efforts and has already
raised some of the necessary funding to assist with the significant costs associated with this
endeavor. 
However, we need to raise much more financial capital before our vaccine candidates
can be validated. 
JP2MRI will need to test our vaccines in an academic BSL3 facility that is
certified to contain infectious pathogens like COVID-19. 
These studies are required by the Food
and Drug Administration and are unfortunately very expensive. 
JP2MRI needs to raise an
additional $500,000 before the end of the year to help defray the costs of producing a pipeline of
attenuated vaccines; produce new adult stem cell lines for vaccine testing; and conduct
preclinical animal testing to identify the lead vaccine candidate that will be selected for more
rigorous efficacy and safety studies. 
It is our hope to develop a more robust, durable and ethical
coronavirus vaccine than those which are currently being administered under the FDA’s
Emergency Use Authorization and which were designed, manufactured and/or tested with
aborted fetal cells. 
The vaccine we are working to develop is a traditional attenuated virus vaccine, it is NOT gene based like the majority of the vaccines currently approved under EUA or developed during Operation Warp Speed. We believe an attenuated virus vaccine is safer and more robust in mounting an immune response.
Please join this important campaign by making a meaningful, tax-deductible
contribution. 
To learn more about our “Campaign for Cures,” please visit jp2mri.org.